Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name Endostim, Inc. Proposed Ticker STIM CUSIP 29272M101 Business Description A medical device company focused on the development and commercialization of a novel neurostimulation system for the treatment of severe gastroesophageal reflux disease, or GERD. Lead Underwriter Wedbush PacGrow Life Sciences Co-Managers Craig-Hallum Capital Group LLC, Roth Capital Partners, Inc Initial Shares 3,200,000 Revised Initial Shares N/A Initial Price $10.00-$12.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.